This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Derma Sciences Inc (DSCI)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 6.50M 41.62M 17.11M 404.22K
Receivables 7.33M 7.09M 6.27M 5.44M
Inventories 16.47M 13.67M 10.53M 12.50M
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 49.53M 69.31M 41.23M 18.95M
Property, Plant & Equipment, Gross 10.31M 10.20M 9.38M 8.72M
Accumulated Depreciation & Depletion 7.36M 6.90M 5.89M 5.11M
Property, Plant & Equipment, Net 2.95M 3.30M 3.49M 3.61M
Intangibles 14.64M 17.13M 6.40M 6.97M
Other Non-Current Assets 8.00M 639.21K 378.82K 316.86K
Total Non-Current Assets 39.04M 34.53M 17.39M 18.02M
Liabilities & Shareholder Equity
Total Assets 88.58M 103.84M 58.62M 36.97M
Accounts Payable 4.52M 3.99M 4.00M 3.78M
Short Term Debt 0.00 0.00 0.00 3.08M
Other Current Liabilities 0.00 0.00 0.00 0.00
Total Current Liabilities 9.49M 8.13M 6.38M 9.01M
Long Term Debt 0.00 268.52K 0.00 0.00
Deferred Income Taxes 1.69M 1.74M 1.15M 1.07M
Other Non-Current Liabilities 242.32K 0.00 252.68K 211.58K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 1.94M 2.00M 1.40M 1.28M
Total Liabilities 11.43M 10.13M 7.78M 10.29M
Preferred Stock Equity 733.00 733.00 733.00 2.85K
Common Stock Equity 77.15M 93.71M 50.85M 26.68M
Common Par 173.47K 165.25K 105.78K 65.63K
Additional Paid In Capital 140.06M 132.16M 77.37M 48.80M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -64.17M -40.21M -28.14M -23.80M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 1.08M 1.59M 1.50M 1.60M
Total Capitalization 77.15M 93.98M 50.85M 26.68M
Total Equity 77.15M 93.71M 50.85M 26.68M
Total Liabilities & Stock Equity 88.58M 103.84M 58.62M 36.97M
Total Common Shares Outstanding 17.35M 16.52M 10.58M 6.56M
Preferred Shares 73.33K 73.33K 73.33K 284.84K
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 17.06M 12.49M 8.78M 6.34M
Diluted Weighted Shares Outstanding 17.06M 12.49M 8.78M 6.34M
Number of Employees 258 237 212 195
Number of Part-Time Employees 4 7 2 0
DSCI News

DSCI Derma Sciences Inc

Analysts Ratings for DSCI

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 3 3 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET DSCI ANALYST REPORT

Brokerage Partners

DSCI Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs